Tag: Arthritis: Drugs
FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis
ACR Issues Position Statements on Drug Pricing, Step Therapy
Statements emphasize need for safe, convenient, affordable access to rheumatology treatments
Cimzia Injection Approved for New Inflammatory Arthritis Indication
FDA grants approval for first treatment for nonradiographic axial spondyloarthritis
Tramadol May Up Mortality Risk in Osteoarthritis Patients
Findings for those initially prescribed tramadol compared with commonly prescribed NSAIDs
Pharmacovigilance Needed for Rheumatology Patients
American College of Rheumatologists urges health care providers to monitor for adverse events
Smoking Impairs Rx Response in Axial Spondyloarthritis
Swiss study authors say inflammation or a lack of oxygen among possible reasons
